Literature DB >> 12837671

Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease.

Philip R Gehrman1, Jennifer L Martin, Tamar Shochat, Sarah Nolan, Jody Corey-Bloom, Sonia Ancoli-Israel.   

Abstract

OBJECTIVE: The authors examined the relationship between sleep-disordered breathing (SDB) and agitation in patients with Alzheimer disease (AD).
METHODS: Thirty-eight AD patients (29 women, 9 men) in nursing homes in San Diego, CA participated. The mean age was 82.3 years, with a range of 61 to 95 years. Mean Mini-Mental State Exam score was 6.5 (range: 0-16). Sleep was recorded for one night, and agitation was measured with behavioral observations and ratings by nursing staff.
RESULTS: SDB was very prevalent in this sample and was related to some types of agitation during the day but not in the evening or night. Aggressive Agitation on the Cohen-Mansfield Agitation Inventory and Manual Manipulation on the Agitated Behavior Rating Scale were greater with more severe SDB. Searching and wandering agitation decreased with more severe SDB.
CONCLUSION: This study supports the hypothesis that SDB is related to agitation in AD, although the results are specific to certain types of agitation. Treatment of SDB may decrease agitation, easing the burden of caregiving and prolonging the time that patients are able to remain at home.

Entities:  

Mesh:

Year:  2003        PMID: 12837671

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  27 in total

Review 1.  The management of sleep and circadian disturbance in patients with dementia.

Authors:  Qiuping Pearl Zhou; Lorena Jung; Kathy C Richards
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  Sleep and Its Disorders in Seniors.

Authors:  Carl J Stepnowsky; Sonia Ancoli-Israel
Journal:  Sleep Med Clin       Date:  2008

Review 3.  Use of sleep-promoting medications in nursing home residents : risks versus benefits.

Authors:  David K Conn; Robert Madan
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Development and evaluation of a sleep education program for older adults with dementia living in adult family homes.

Authors:  Susan M McCurry; David M LaFazia; Kenneth C Pike; Rebecca G Logsdon; Linda Teri
Journal:  Am J Geriatr Psychiatry       Date:  2012-06       Impact factor: 4.105

Review 5.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

6.  Normal and abnormal sleep in the elderly.

Authors:  Jana R Cooke; Sonia Ancoli-Israel
Journal:  Handb Clin Neurol       Date:  2011

Review 7.  Sleep-disordered breathing in neurodegenerative diseases.

Authors:  Carles Gaig; Alex Iranzo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

8.  Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.

Authors:  Ricardo S Osorio; Indu Ayappa; Janna Mantua; Tyler Gumb; Andrew Varga; Anne M Mooney; Omar E Burschtin; Zachary Taxin; Emmanuel During; Nicole Spector; Milton Biagioni; Elizabeth Pirraglia; Hiuyan Lau; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; David M Rapoport; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

9.  Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea.

Authors:  Jana R Cooke; Sonia Ancoli-Israel; Lianqi Liu; Jose S Loredo; Loki Natarajan; Barton S Palmer; Feng He; Jody Corey-Bloom
Journal:  Sleep Med       Date:  2009-08-20       Impact factor: 3.492

Review 10.  Obstructive Sleep Apnea is Linked to Depression and Cognitive Impairment: Evidence and Potential Mechanisms.

Authors:  Nancy A Kerner; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-29       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.